| Trial ID: | L0142 |
| Source ID: | NCT02242149
|
| Associated Drug: |
Diacerein
|
| Title: |
Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects
|
| Acronym: |
DGCLFT2DM
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Diabetes Mellitus, Type 2|Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Diacerein|Drug: Placebo
|
| Outcome Measures: |
Evidence of improvement in glycemic control and improvement in liver steatosis|Improvement of microalbuminuria|Changes of adipocytokines and cytokeratin-18
|
| Sponsor/Collaborators: |
Universidade Federal do Rio de Janeiro|Rio de Janeiro State Research Supporting Foundation (FAPERJ)
|
| Gender: |
All
|
| Age: |
30 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 3
|
| Enrollment: |
84
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
October 14, 2014
|
| Completion Date: |
January 31, 2018
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 3, 2018
|
| Locations: |
Program of Arterial Hypertension, University Hospital Clementino Fraga Filho, Rio de Janeiro, Brazil
|
| URL: |
https://ClinicalTrials.gov/show/NCT02242149
|
